Literature DB >> 218633

Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.

C J Packard, J Shepherd, S Joerns, A M Gotto, O D Taunton.   

Abstract

Subfractions of CLDL (VLDL), Sf 100-400; CLDL2, Sf 60--100; VLDL3, Sf 20--60) and LDL (LDL), Sf 12--20; LDL2, Sf 6--12; LDL3, Sf 3--6) were isolated from the plasma of three normal, three type III and four type IV hyperlipoproteinemic subjects. In the type IV group, all VLDL subspecies were of normal composition but were increased in concentration in the order VLDL1 greater than VLDL2 greater than VLDL3. In the same subjects, although LDL2 was lowered and LDL3 increased, the total plasma LDL concentration was normal. All VLDL subfractions were elevated in the type III group, but in this case VLDL3 predominated. These subfractions were enriched in cholesteryl esters and depleted in triglyceride. In the LDL density range there was a shift of mass towards the least dense fraction, LDL1, which was of normal composition. EPR studies of the VLDL and LDL subfractions in a type IV subject demonstrated a decrease in fluidity with increasing density. The major change occurred between VLDL3 and LDL1 and was attributed to a substantial alteration in the cholesteryl ester : triglyceride ratio in the particle. A similar argument was used to explain thction in normal or type IV subjects. Particle diameters, determined by laser light-scattering spectroscopy were in good agreement with the values obtained by electron microscopy. This study provides a baseline for the examination of the relationship between the physical and metabolic properties of VLDL and LDL subfractions in type III and IV hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218633     DOI: 10.1016/0005-2760(79)90042-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

3.  Sedimentation equilibrium of human low density lipoprotein subfractions.

Authors:  T S Kahlon; G L Adamson; M M Shen; F T Lindgren
Journal:  Lipids       Date:  1982-05       Impact factor: 1.880

4.  Lipoprotein size distributions from the analytical ultracentrifugation of serum and lipoprotein samples.

Authors:  A G Bosanquet; R Bickerstaffe; I T Viney; R Fraser
Journal:  Med Biol Eng Comput       Date:  1980-11       Impact factor: 2.602

5.  Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses.

Authors:  S H Gianturco; C J Packard; J Shepherd; L C Smith; A L Catapano; H D Sybers; A M Gotto
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

6.  A low density lipoprotein-methotrexate covalent complex and its activity against L1210 cells in vitro.

Authors:  G W Halbert; J F Stuart; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Authors:  C J Packard; A Munro; A R Lorimer; A M Gotto; J Shepherd
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.